Evaluation of Alexithymia in Chronic Pain Patients With Spinal Cord Stimulation
The Relationship of Alexithymia With Pain and Quality of Life Scales in Chronic Pain Patients Who Underwent Spinal Cord Stimulation: A Cross-Sectional Observational Study
The purpose of this study is to investigate the relationship between alexithymia levels and clinical parameters, including pain intensity and quality of life, in chronic pain patients treated with spinal cord stimulation (SCS). Chronic neuropathic pain can lead to psychological distress and decreased quality of life. While SCS is an effective neuromodulation therapy for managing refractory pain, patient outcomes vary significantly, suggesting that biomedically similar patients experience different levels of relief due to psychosocial factors.
Alexithymia, characterized by difficulties in identifying and describing emotions, may significantly influence the individual pain experience and treatment outcomes. In this cross-sectional observational study, patients who underwent SCS implantation for clinical indications will be evaluated. Clinical data regarding pain history will be collected retrospectively from patient files, while psychosocial profiles will be assessed at a single time point using validated psychometric questionnaires. The study aims to contribute to a better understanding of psychosocial variables in neuromodulation outcomes, potentially aiding in improved patient selection and expectation management.
연구 개요
상세 설명
Chronic pain is a multidimensional clinical syndrome that can lead to decreased functionality, sleep and mood disorders, loss of social and occupational roles, and a significant reduction in quality of life. In chronic neuropathic pain cases, spinal cord stimulation (SCS) is increasingly used as a neuromodulation-based, reversible, and minimally invasive treatment option. However, responses to SCS in clinical practice are heterogeneous, and functional gains vary among patients with similar biomedical characteristics, suggesting that outcomes are influenced by psychosocial factors.
This single-center, non-interventional, cross-sectional observational analytical study aims to investigate the relationship between alexithymia levels and clinical parameters in chronic pain patients who underwent SCS implantation at the Marmara University Pendik Training and Research Hospital Algology Clinic between January 2023 and May 2026.
Clinical data (Visual Analog Scale/Numeric Rating Scale for pain intensity and SF-12 data) will be collected retrospectively from patient files. Psychometric evaluations will be performed at a single time point using validated self-report questionnaires during a single session lasting approximately 25-35 minutes. No repetitive measurements or follow-up visits are planned for research purposes.
The evaluation tools include:
- Sociodemographic Data Form: Captures clinical and demographic characteristics.
- Toronto Alexithymia Scale (TAS-20): Assesses difficulties identifying emotions, difficulties describing emotions, and externally-oriented thinking.
- Hospital Anxiety and Depression Scale (HADS): Measures anxiety and depression levels to control for mood symptoms as potential confounding factors.
- Short Form Health Survey (SF-12): Evaluates health-related quality of life.
- Childhood Trauma Questionnaire (CTQ-33): Assesses retrospective childhood and adolescent adverse experiences (emotional, physical, and sexual abuse; emotional and physical neglect; overprotection-control).
- Visual Analog Scale (VAS): Measures current pain intensity on a 0-10 cm horizontal line.
The primary objective is to evaluate the relationship between alexithymia levels, pain intensity, and quality of life scales. Secondary objectives include analyzing the relationship between alexithymia and patient-reported outcomes (functionality, pain, and life quality), evaluating the potential confounding effects of childhood trauma and anxiety/depression symptoms on this relationship, and providing insights into how psychosocial factors influence clinical measurement tools.
연구 유형
등록 (추정된)
연락처 및 위치
연구 장소
-
-
-
Istanbul, 터키 (Türkiye)
- 모병
- Marmara University Pendik Training and Research Hospital
-
연락하다:
- Osman Hakan Gunduz, Prof. MD
- 전화번호: 02166570606
- 이메일: ipek98uyanik@gmail.com
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- - Being 18 years of age or older
- Having undergone permanent spinal cord stimulation (SCS) implantation due to clinical indications
- Providing written informed consent for study participation
- Being literate
- Having the cognitive capacity to complete the psychometric scales
- No active, severe psychiatric disorders requiring immediate treatment (e.g., schizophrenia, bipolar affective disorder, severe psychotic disorders)
Exclusion Criteria:
- Cognitive impairment or communication barriers that compromise the capacity to provide informed consent
- Presence of active psychotic disorders or manic episodes
- Suspected self-harm or suicide risk during the clinical interview
- Presence of specific secondary causes that could explain the pain (e.g., active malignancy, active infection, acute fracture)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
SCS Chronic Pain Patients
Chronic pain patients aged 18 and older who have undergone permanent spinal cord stimulation (SCS) implantation due to clinical indications.
|
Participants are evaluated at a single time point using self-report questionnaires including the Toronto Alexithymia Scale (TAS-20), Hospital Anxiety and Depression Scale (HADS), Short Form Health Survey (SF-12), and Childhood Trauma Questionnaire (CTQ-33).
Pain intensity (VAS/NRS) and clinical data are extracted retrospectively from medical records.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Toronto Alexithymia Scale (TAS-20) Score
기간: At a single time point (during the cross-sectional evaluation)
|
A 20-item self-report questionnaire used to assess alexithymia levels.
It evaluates three subscales: difficulty identifying feelings, difficulty describing feelings, and externally-oriented thinking.
Total scores range from 20 to 100, with higher scores indicating higher levels of alexithymia.
|
At a single time point (during the cross-sectional evaluation)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Visual Analog Scale (VAS) Score
기간: At a single time point (during the cross-sectional evaluation)
|
A 10 cm horizontal scale used to measure current pain intensity, where 0 represents no pain and 10 represents the most severe pain.
|
At a single time point (during the cross-sectional evaluation)
|
|
Short Form Health Survey (SF-12) Score
기간: At a single time point (during the cross-sectional evaluation)
|
A 12-item questionnaire used to assess health-related quality of life across 8 dimensions.
Total scores range from 0 to 100, with higher scores indicating better quality of life.
|
At a single time point (during the cross-sectional evaluation)
|
|
Hospital Anxiety and Depression Scale (HADS) Score
기간: At a single time point (during the cross-sectional evaluation)
|
A 14-item self-report scale with anxiety and depression subscales (7 items each).
Scores for each subscale range from 0 to 21, with higher scores indicating higher symptom severity.
|
At a single time point (during the cross-sectional evaluation)
|
|
Childhood Trauma Questionnaire (CTQ-33) Score
기간: At a single time point (during the cross-sectional evaluation)
|
A 33-item self-report scale evaluating retrospective childhood and adolescent adverse experiences.
Higher scores indicate an increased level of trauma.
|
At a single time point (during the cross-sectional evaluation)
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
만성 통증에 대한 임상 시험
-
Hospital Clinic of BarcelonaAstraZeneca완전한CTO(Chronic Total Occlusion)를 위한 PCI(Percutaneous Coronary Intervention)를 받을 예정인 환자스페인
-
Bingol UniversityAtaturk University아직 모집하지 않음수술 전 불안 | 두려움 | PAIN
-
Weill Medical College of Cornell UniversityNew York University; National Center for Complementary and Integrative Health (NCCIH)모병
-
Istanbul University모병Masticatory Muscle Pain | 근시 통증 증후군 (MP)칠면조
-
Istanbul University모병이갈이 | 근막 통증 증후군 | Masticatory Muscle Pain | 현지 근육통터키 (Türkiye)